Published in Eur J Nucl Med Mol Imaging on March 26, 2003
The International Neuroblastoma Risk Group (INRG) staging system: an INRG Task Force report. J Clin Oncol (2008) 2.94
Proposal for standardization of 123I-metaiodobenzylguanidine (MIBG) cardiac sympathetic imaging by the EANM Cardiovascular Committee and the European Council of Nuclear Cardiology. Eur J Nucl Med Mol Imaging (2010) 1.49
Criteria for evaluation of disease extent by (123)I-metaiodobenzylguanidine scans in neuroblastoma: a report for the International Neuroblastoma Risk Group (INRG) Task Force. Br J Cancer (2010) 1.19
¹²³I-MIBG scintigraphy/SPECT versus ¹⁸F-FDG PET in paediatric neuroblastoma. Eur J Nucl Med Mol Imaging (2011) 1.00
Comparison of iodine-123 metaiodobenzylguanidine (MIBG) scan and [18F]fluorodeoxyglucose positron emission tomography to evaluate response after iodine-131 MIBG therapy for relapsed neuroblastoma. J Clin Oncol (2009) 1.00
131I/123I-metaiodobenzylguanidine (mIBG) scintigraphy: procedure guidelines for tumour imaging. Eur J Nucl Med Mol Imaging (2010) 0.99
The radiation burden of radiological investigations. Arch Dis Child (2007) 0.94
Prognostic value of ¹⁸F-DOPA PET/CT at the time of recurrence in patients affected by neuroblastoma. Eur J Nucl Med Mol Imaging (2014) 0.91
MIBG scans in patients with stage 4 neuroblastoma reveal two metastatic patterns, one is associated with MYCN amplification and in MYCN-amplified tumours correlates with a better prognosis. Eur J Nucl Med Mol Imaging (2014) 0.83
High ¹²³I-MIBG uptake in neuroblastic tumours indicates unfavourable histopathology. Eur J Nucl Med Mol Imaging (2013) 0.82
Combined Scintigraphy and Tumor Marker Analysis Predicts Unfavorable Histopathology of Neuroblastic Tumors with High Accuracy. PLoS One (2015) 0.78
(123)I-mIBG scintigraphy in neuroblastoma: development of a SIOPEN semi-quantitative reporting ,method by an international panel. Eur J Nucl Med Mol Imaging (2016) 0.78
Staging of common paediatric tumours. Pediatr Radiol (2009) 0.78
Semi-quantitative scoring of skeletal metastases by (123)I-mIBG scintigraphy in high-risk neuroblastoma. Eur J Nucl Med Mol Imaging (2017) 0.75
Cancer incidence, survival, and mortality for children younger than age 15 years. Cancer (1986) 1.93
Iodine-131 metaiodobenzylguanidine for the locating of suspected pheochromocytoma: experience in 400 cases. J Nucl Med (1985) 1.72
Neuroblastoma, its natural history and prognosis: a study of 487 cases. Br Med J (1974) 1.65
Radiolabeled adrenergi neuron-blocking agents: adrenomedullary imaging with [131I]iodobenzylguanidine. J Nucl Med (1980) 1.62
Skeletal assessment in neuroblastoma--the pitfalls of iodine-123-MIBG scans. J Nucl Med (1990) 1.48
A radiopharmaceuticals schedule for imaging in paediatrics. Paediatric Task Group European Association Nuclear Medicine. Eur J Nucl Med (1990) 1.32
A pharmacological guide to medicines which interfere with the biodistribution of radiolabelled meta-iodobenzylguanidine (MIBG). Nucl Med Commun (1992) 1.26
The normal and abnormal distribution of the adrenomedullary imaging agent m-[I-131]iodobenzylguanidine (I-131 MIBG) in man: evaluation by scintigraphy. J Nucl Med (1983) 1.00
Current concepts on the diagnostic use of MIBG in children. J Nucl Med (1998) 1.00
Nuclear medicine imaging of pheochromocytoma and neuroblastoma. Q J Nucl Med (1999) 0.96
Dosimetry of pediatric nuclear medicine procedures. Q J Nucl Med (1998) 0.94
Refining interpretation of MIBG scans in children. J Nucl Med (1994) 0.93
Specificity of radioiodinated MIBG for neural crest tumors in childhood. J Nucl Med (1997) 0.91
Meta-iodobenzylguanidine in children. Semin Nucl Med (1993) 0.87
Therapeutic use of [131I]metaiodobenzylguanidine in neuroblastoma: a phase II study in 26 patients. "Société Française d'Oncologie Pédiatrique" and Nuclear Medicine Co-investigators. J Nucl Biol Med (1992) 0.87
Clinical impact and prognostic value of metaiodobenzylguanidine imaging in children with metastatic neuroblastoma. J Pediatr Hematol Oncol (1999) 0.85
Neuroblastoma therapy using radiolabelled [131I]meta-iodobenzylguanidine ([131I]MIBG) in combination with other agents. Eur J Cancer (1999) 0.82
Efficacy of metaiodobenzylguanidine as a scintigraphic agent for the detection of neuroblastoma. Invest Radiol (1992) 0.81
Meta-iodobenzylguanidine (mIBG) scans in neuroblastoma: sensitivity and specificity, a review of 115 scans. Prog Clin Biol Res (1988) 0.79
[131I]MIBG as a first line treatment in advanced neuroblastoma. Q J Nucl Med (1995) 0.79
Iodine-123-MIBG SPECT versus planar imaging in children with neural crest tumors. J Nucl Med (1994) 0.79
Phaeochromocytoma and functioning paraganglioma in childhood and adolescence: role of iodine 131 metaiodobenzylguanidine. Eur J Nucl Med (1991) 0.78
[123I]MIBG scintigraphy in neuroblastoma: a comparison between planar and SPECT imaging. Q J Nucl Med (1995) 0.78
Paediatric nuclear medicine procedures: routine sedation or management of anxiety? Nucl Med Commun (1994) 0.78
Iodine-123-MIBG imaging of neuroblastoma: utility of SPECT and delayed imaging. J Nucl Med (1996) 0.77
Consolidating the role of *I-MIBG-scintigraphy in childhood neuroblastoma: five years of clinical experience. Pediatr Radiol (1990) 0.76
Upper clavicular and cardiac meta-[123I]iodobenzylguanidine uptake in children. Q J Nucl Med (1995) 0.75
FDG PET/CT: EANM procedure guidelines for tumour imaging: version 2.0. Eur J Nucl Med Mol Imaging (2014) 2.79
Guidelines for imaging and staging of neuroblastic tumors: consensus report from the International Neuroblastoma Risk Group Project. Radiology (2011) 2.35
The Swedish reflux trial in children: IV. Renal damage. J Urol (2010) 2.32
Hippocampal changes in patients with a first episode of major depression. Am J Psychiatry (2002) 2.15
Advances in molecular labeling, high throughput imaging and machine intelligence portend powerful functional cellular biochemistry tools. J Cell Biochem Suppl (2002) 2.14
Biosensors for characterizing the dynamics of rho family GTPases in living cells. Curr Protoc Cell Biol (2010) 2.11
FDG and FDG-labelled leucocyte PET/CT in the imaging of prosthetic joint infection. Eur J Nucl Med Mol Imaging (2013) 2.03
Predictive factors for resolution of congenital high grade vesicoureteral reflux in infants: results of univariate and multivariate analyses. J Urol (2010) 1.99
Neutrophil polarization: spatiotemporal dynamics of RhoA activity support a self-organizing mechanism. Proc Natl Acad Sci U S A (2006) 1.89
Relationship among vesicoureteral reflux, urinary tract infection and renal damage in children. J Urol (2007) 1.84
Tpr is localized within the nuclear basket of the pore complex and has a role in nuclear protein export. J Cell Biol (2002) 1.79
Sixty-four slice spiral CT angiography does not predict the functional relevance of coronary artery stenoses in patients with stable angina. Eur J Nucl Med Mol Imaging (2006) 1.70
Renal angiography in children with polyarteritis nodosa. Pediatr Nephrol (2002) 1.68
Synthesis of some novel heterocyclic compounds derived from diflunisal hydrazide as potential anti-infective and anti-inflammatory agents. Eur J Med Chem (2007) 1.60
Imaging and photobleach correction of Mero-CBD, sensor of endogenous Cdc42 activation. Methods Enzymol (2006) 1.60
Solvent-sensitive dyes to report protein conformational changes in living cells. J Am Chem Soc (2003) 1.57
Renal function in adult women with urinary tract infection in childhood. Pediatr Nephrol (2015) 1.46
Clinical audit in nuclear medicine. Nucl Med Commun (2004) 1.44
Imaging strategy for infants with urinary tract infection: a new algorithm. J Urol (2011) 1.43
The predictive value of the renogram. Eur J Nucl Med Mol Imaging (2009) 1.43
Angioplasty for renovascular hypertension in children: 20-year experience. Pediatrics (2006) 1.43
¹⁸F-Fluorocholine PET/CT for localization of hyperfunctioning parathyroid tissue in primary hyperparathyroidism: a pilot study. Eur J Nucl Med Mol Imaging (2014) 1.42
Chromophore-assisted laser inactivation in cell biology. Trends Cell Biol (2008) 1.42
Change of urodynamic patterns in infants with dilating vesicoureteral reflux: 3-year followup. J Urol (2009) 1.42
Training of staff for the delivery of PET/CT services in the UK. Nucl Med Commun (2006) 1.39
Influence of renal function on renal output efficiency. J Nucl Med (2002) 1.39
Enlargement of the amygdala in patients with a first episode of major depression. Biol Psychiatry (2002) 1.38
The delta subunit of AP-3 is required for efficient transport of VSV-G from the trans-Golgi network to the cell surface. Proc Natl Acad Sci U S A (2002) 1.32
(68)Ga-PSMA PET/CT imaging of metastatic clear cell renal cell carcinoma. Eur J Nucl Med Mol Imaging (2014) 1.26
Normal dimercaptosuccinic acid scintigraphy makes voiding cystourethrography unnecessary after urinary tract infection. J Pediatr (2007) 1.26
Dimercapto-succinic acid scintigraphy instead of voiding cystourethrography for infants with urinary tract infection. J Urol (2004) 1.23
Localized tensional forces on PECAM-1 elicit a global mechanotransduction response via the integrin-RhoA pathway. Curr Biol (2012) 1.20
EANM procedure guideline for treatment of refractory metastatic bone pain. Eur J Nucl Med Mol Imaging (2008) 1.18
Relationship between acute pyelonephritis, renal scarring, and vesicoureteral reflux. Results of a coordinated research project. Pediatr Nephrol (2004) 1.16
Phase II study of temozolomide in relapsed or refractory high-risk neuroblastoma: a joint Société Française des Cancers de l'Enfant and United Kingdom Children Cancer Study Group-New Agents Group Study. J Clin Oncol (2006) 1.15
Guidelines for standard and diuretic renogram in children. Eur J Nucl Med Mol Imaging (2011) 1.13
Integrated imaging using MRI and 123I metaiodobenzylguanidine scintigraphy to improve sensitivity and specificity in the diagnosis of pediatric neuroblastoma. AJR Am J Roentgenol (2003) 1.09
Comparison of spiral multidetector CT angiography and myocardial perfusion imaging in the noninvasive detection of functionally relevant coronary artery lesions: first clinical experiences. J Nucl Med (2005) 1.05
When could the administration of furosemide be avoided? Clin Nucl Med (2003) 1.03
Visualizing and quantifying adhesive signals. Curr Opin Cell Biol (2008) 1.02
Value of PET/CT versus PET and CT performed as separate investigations in patients with Hodgkin's disease and non-Hodgkin's lymphoma. Eur J Nucl Med Mol Imaging (2006) 1.02
Digital autofocus methods for automated microscopy. Methods Enzymol (2006) 1.01
The fault is not in her parents but in her insula--a neurobiological hypothesis of anorexia nervosa. Eur Eat Disord Rev (2008) 1.01
131I/123I-metaiodobenzylguanidine (mIBG) scintigraphy: procedure guidelines for tumour imaging. Eur J Nucl Med Mol Imaging (2010) 0.99
Functional proteometrics for cell migration. Cytometry A (2006) 0.99
D2 receptor occupancy during high- and low-dose therapy with the atypical antipsychotic amisulpride: a 123I-iodobenzamide SPECT study. J Nucl Med (2005) 0.98
18F-FDG PET/CT for staging of penile cancer. J Nucl Med (2005) 0.97
Fluctuation analysis of activity biosensor images for the study of information flow in signaling pathways. Methods Enzymol (2013) 0.96
Additional Benefit of F-18 FDG PET/CT in the staging and follow-up of pediatric rhabdomyosarcoma. Clin Nucl Med (2011) 0.95
Value of 99mTc-TRODAT-1 SPECT to predict clinical response to methylphenidate treatment in adults with attention deficit hyperactivity disorder. Nucl Med Commun (2006) 0.95
p190RhoGAP negatively regulates Rho activity at the cleavage furrow of mitotic cells. Exp Cell Res (2009) 0.95
Primary vesicoureteral reflux detected in neonates with a history of fetal renal pelvis dilatation: a prospective clinical and imaging study. J Pediatr (2006) 0.95
The Swedish reflux trial in children: I. Study design and study population characteristics. J Urol (2010) 0.94
Decreased lung function and exercise capacity in Fontan patients. A long-term follow-up. Scand Cardiovasc J (2003) 0.94
Malignant pheochromocytoma. Front Horm Res (2004) 0.93
Antiapoptotic Cdc42 mutants are potent activators of cellular transformation. Biochemistry (2002) 0.92
Biliobronchial fistula after liver surgery for giant hydatid cyst. HPB Surg (2011) 0.92
Interpretation of the renogram: problems and pitfalls in hydronephrosis in children. BJU Int (2004) 0.92
Insights into the pathogenesis and natural history of fetuses with renal pelvis dilatation. Eur Urol (2005) 0.91
Functional neuroimaging in early-onset anorexia nervosa. Int J Eat Disord (2005) 0.90
Is the I-131 whole-body scanning proper for follow-up management of the patients with malignant struma ovarii without performing the thyroidectomy? Gynecol Oncol (2005) 0.90
Imaging in childhood urinary tract infections: time to reduce investigations. Pediatr Nephrol (2007) 0.90
International Scientific Committee of Radionuclides in Nephrourology (ISCORN) consensus on renal transit time measurements. Semin Nucl Med (2008) 0.90
Test-retest reliability and repeatability of renal diffusion tensor MRI in healthy subjects. Eur J Radiol (2011) 0.89
The relevance of urodynamic studies for Urge syndrome and dysfunctional voiding: a multicenter controlled trial in children. J Urol (2008) 0.88
Leukotriene receptor blocker montelukast protects against burn-induced oxidative injury of the skin and remote organs. Burns (2005) 0.88
Shedding light on cell signaling: interpretation of FRET biosensors. Sci STKE (2003) 0.88
Clinical applications of newer radionuclide therapies. Eur J Cancer (2006) 0.87
Normal distribution pattern and physiological variants of 68Ga-PSMA-11 PET/CT imaging. Nucl Med Commun (2016) 0.87
F-18-fluoro-2-deoxyglucose positron emission tomography/computed tomography in the follow-up of breast cancer with elevated levels of tumor markers. J Comput Assist Tomogr (2007) 0.86
Changing paradigms in radioguided surgery and intraoperative imaging: the GOSTT concept. Eur J Nucl Med Mol Imaging (2012) 0.86
Guidance document for structured reporting of diuresis renography. Semin Nucl Med (2012) 0.86
Improvement of MRI-functional measurement with automatic movement correction in native and transplanted kidneys. J Magn Reson Imaging (2008) 0.86
Longitudinal development of renal damage and renal function in infants with high grade vesicoureteral reflux. J Urol (2009) 0.85
Preoperative imaging of Charcot neuroarthropathy in diabetic patients: comparison of ring PET, hybrid PET, and magnetic resonance imaging. Foot Ankle Int (2004) 0.85
The value of radionuclide studies in children with autosomal recessive polycystic kidney disease. Clin Nucl Med (2002) 0.85
The guanine-nucleotide exchange factor SGEF plays a crucial role in the formation of atherosclerosis. PLoS One (2013) 0.85
Ginkgo biloba extract protects against ionizing radiation-induced oxidative organ damage in rats. Pharmacol Res (2006) 0.85
Long-term administration of aqueous garlic extract (AGE) alleviates liver fibrosis and oxidative damage induced by biliary obstruction in rats. Life Sci (2005) 0.85
Urinary proteins in children with urinary tract infection. Pediatr Nephrol (2009) 0.84
Temporal relationship between gastroesophageal reflux and rate of gastric emptying in children. Nucl Med Commun (2010) 0.84
Impact of (18)F-FDG PET on treatment strategy and 3D radiotherapy planning in non-small cell lung cancer: A prospective multicenter study. AJR Am J Roentgenol (2010) 0.84
Evaluation and comparison of Ga-68 DOTA-TATE and Ga-68 DOTA-NOC PET/CT imaging in well-differentiated thyroid cancer. Nucl Med Commun (2013) 0.84
Repeatability of renal arterial spin labelling MRI in healthy subjects. MAGMA (2012) 0.84
Value of ultrasound in evaluation of infants with first urinary tract infection. J Urol (2010) 0.83
Malignant pheochromocytomas and paragangliomas: a diagnostic challenge. Langenbecks Arch Surg (2011) 0.83
Impact of 18F-fluoro-2-deoxyglucose positron emission tomography on treatment strategy and radiotherapy planning for stage I-II Hodgkin disease: a prospective multicenter study. Int J Radiat Oncol Biol Phys (2010) 0.83
Precise measurement of renal filtration and vascular parameters using a two-compartment model for dynamic contrast-enhanced MRI of the kidney gives realistic normal values. Eur Radiol (2012) 0.83
Ultrasonography in the evaluation of renal scarring using DMSA scan as the gold standard. Pediatr Nephrol (2003) 0.83
EANM practice guidelines for lymphoscintigraphy and sentinel lymph node biopsy in melanoma. Eur J Nucl Med Mol Imaging (2015) 0.83
Clinical governance improves the quality of nuclear medicine reporting. Nucl Med Commun (2008) 0.83
EANM procedure guideline for radio-immunotherapy for B-cell lymphoma with 90Y-radiolabelled ibritumomab tiuxetan (Zevalin). Eur J Nucl Med Mol Imaging (2007) 0.83
Changes in caveolin-1 expression and vasoreactivity in the aorta and corpus cavernosum of fructose and streptozotocin-induced diabetic rats. Eur J Pharmacol (2010) 0.83
Clinical validation of the gated blood pool SPECT QBS processing software in congestive heart failure patients: correlation with MUGA, first-pass RNV and 2D-echocardiography. Int J Cardiovasc Imaging (2005) 0.83
Current management of infants with fetal renal pelvis dilation: a survey by French-speaking pediatric nephrologists and urologists. Pediatr Nephrol (2004) 0.82
Measurement of glomerular filtration rate with magnetic resonance imaging: principles, limitations, and expectations. Semin Nucl Med (2008) 0.82
Evolution of individual renal function in children with unilateral complex renal duplication. J Pediatr (2005) 0.82